FIELD: biotechnology, medicine.
SUBSTANCE: invention relates to media used for cryoconservation of human and animal cells. Medium contains calf embryo serum, dimethylsulfoxide, medium RPMI-1640, antibiotics, acetamide, D-glucuronic acid, lecithin, cholesterol, linoleic acid taken in the definite ratio of components. Invention provides enhancing viability of cells due to enhancement of their resistance to cryoconservation and reducing toxic effect of cryoprotecting agent.
EFFECT: valuable properties of medium.
2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCTION OF MESENCHYMAL STEM CELLS AND BIOTRANSPLANT USING THE SAME | 2006 |
|
RU2303631C1 |
| MEDIUM FOR REPROGRAMMING HUMAN AND ANIMAL STEM CELLS | 2003 |
|
RU2260621C2 |
| MEDIUM FOR CONSERVATION OF LANGERHANS ISLETS | 2005 |
|
RU2290433C2 |
| MEDIUM FOR CONSERVATION OF SPLENIC CELLS | 2001 |
|
RU2194753C2 |
| METHOD OF PRODUCING MONOCLONAL ANTIBODIES TO LIGHT CHAINS OF HUMAN IMMUNOGLOBULIN | 0 |
|
SU1402617A1 |
| CRYOPRESERVANT COMPOSITION FOR LONG-TERM STORAGE OF PRIMARY KERATINOCYTES | 2019 |
|
RU2731065C1 |
| METHOD FOR EXPANSION OF HUMAN NK CELLS USING FEEDER CELLS | 2021 |
|
RU2781777C2 |
| METHOD OF PRODUCING MONOCLONAL ANTIBODIES TO LIGHT CHAINS OF HUMAN IMMUNOGLOBULINS | 0 |
|
SU1416509A1 |
| CELL LINE OF HUMAN MELANOMA mel Cher, USED FOR OBTAINING ANTI-TUMOR VACCINES | 2008 |
|
RU2364624C1 |
| HUMAN MELANOMA CELL LINE mel Ksen, USED FOR ANTITUMOUR VACCINES MANUFACTURE | 2008 |
|
RU2392316C1 |
